Cardiac Unit, Great Ormond Street Hospital for Children NHS Foundation Trust and Institute for Cardiovascular Science University College London, London, United Kingdom.
Pediatr Crit Care Med. 2013 Jun;14(5 Suppl 1):S73-83. doi: 10.1097/PCC.0b013e318292e3fc.
Extracorporeal membrane oxygenation is a commonly used form of mechanical circulatory support in children with congenital or acquired heart disease and cardiac failure refractory to conventional medical therapies. In children with heart disease who suffer cardiac arrest, extracorporeal membrane oxygenation has been successfully used to provide cardiopulmonary support when conventional resuscitation has failed to establish return of spontaneous circulation. Survival to hospital discharge for children with heart disease support is approximately 40% but varies widely based on age, indication for support, and underlying cardiac disease. Although extracorporeal membrane oxygenation is lifesaving in many instances, it is associated with many complications and is expensive. Thus, a clear understanding of survival to discharge and long-term functional and neurologic outcomes are essential to guide the use of extracorporeal membrane oxygenation now and in the future. This review, part of the Pediatric Cardiac Intensive Care Society/Extracorporeal Life Support Organization Joint Statement on Mechanical Circulatory Support, summarizes current knowledge on short- and long-term outcomes for extracorporeal membrane oxygenation used to support children with cardiac disease.
体外膜肺氧合是一种常用于患有先天性或后天性心脏病和心力衰竭的儿童的机械循环支持形式,这些患儿对常规药物治疗无效。在患有心脏病并发生心脏骤停的儿童中,当常规复苏未能恢复自主循环时,体外膜肺氧合已成功用于提供心肺支持。接受心脏病支持治疗的儿童的出院存活率约为 40%,但差异很大,取决于年龄、支持指征和基础心脏病。尽管体外膜肺氧合在许多情况下是救生的,但它也与许多并发症有关,并且费用昂贵。因此,明确了解出院时的生存率以及长期的功能和神经学结果对于指导现在和未来使用体外膜肺氧合至关重要。这篇综述是儿科心脏重症监护学会/体外生命支持组织关于机械循环支持联合声明的一部分,总结了体外膜肺氧合用于支持患有心脏病的儿童的短期和长期结果的现有知识。